Answers are grounded in this paper and cite their sources.
We report on a 33-year-old female patient with a relatively mild clinical case of TNF-receptor associated periodic syndrome (TRAPS) and her 58-year-old father in whom end-stage renal disease due to TRAPS-related AA-amyloidosis has already developed. TRAPS was caused by a I170N mutation that has previously not been associated with amyloidosis. It remains unclear if an only mildly affected patient such as ours would benefit from treatment considering her father’s severe course of disease. The relevant literature on this problem is reviewed.
No takes yet. Share an insight, caveat, or question.
Lehmann et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: